Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |